A systematic review and meta-analysis for the management of Paget-Schroetter syndrome

Karaolanis, Georgios; Antonopoulos, Constantine N.; Koutsias, Stylianos; Giosdekos, Alexandros; Metaxas, Efstathios K.; Τζίμας, Πέτρος; Borst, Gert J. de; Geroulakos, George

doi:10.1016/j.jvsv.2021.01.011

Cited by 25 publications

(25 citation statements)

References 43 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…To achieve this, endovascular therapy is most often indicated with catheter directed thrombolysis, and/or thrombectomy followed by oral anticoagulation. Even though stent insertion could be considered a rational choice for immediate treatment, evidence suggests that it is associated with recurrent thrombosis which is precipitated from the unresolved external pressure to the vessel ( 46 , 47 ). After completion of a period on anticoagulation, the patients are subsequently referred for First Rib Resection (FRR) in order to release the external pressure to the vein.…”

Section: Discussionmentioning

confidence: 99%

“…After completion of a period on anticoagulation, the patients are subsequently referred for First Rib Resection (FRR) in order to release the external pressure to the vein. Currently, there is no universally accepted guidelines on the exact timeframe for surgical referral ( 47 ). However, a systematic review, published in 2020, showed that despite the limited data available, decompression of thoracic outlet can be safely performed within 2 weeks from catheter thrombolysis ( 48 ).…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Thoracic Outlet Syndrome: Single Center Experience on Robotic Assisted First Rib Resection and Literature Review

et al. 2022

View full text Add to dashboard Cite

BackgroundThoracic outlet syndrome (TOS) is a pathological condition caused by a narrowing between the clavicle and first rib leading to a compression of the neurovascular bundle to the upper extremity. The incidence of TOS is probably nowadays underestimated because the diagnosis could be very challenging without a thorough clinical examination along with appropriate clinical testing. Beside traditional supra-, infraclavicular or transaxillary approaches, the robotic assisted first rib resection has been gaining importance in the last few years.MethodsWe conducted a retrospective cohort analysis of all patients who underwent robotic assisted first rib resection due to TOS at Lucerne Cantonal Hospital and then we performed a narrative review of the English literature using PubMed, Cochrane Database of Systematic Reviews and Scopus.ResultsBetween June 2020 and November 2021, eleven robotic assisted first rib resections were performed due to TOS at Lucerne Cantonal Hospital. Median length of stay was 2 days (Standard Deviation: +/– 0.67 days). Median surgery time was 180 min (Standard Deviation: +/– 36.5). No intra-operative complications were reported.ConclusionsRobotic assisted first rib resection could represent a safe and feasible option in expert hands for the treatment of thoracic outlet syndrome.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Thoracic Outlet Syndrome: Single Center Experience on Robotic Assisted First Rib Resection and Literature Review

et al. 2022

View full text Add to dashboard Cite

show abstract

“…Parenteral anticoagulation will help prevent extension of thrombus while additional workup and more definitive treatment strategies are pursued. 2 14…”

Section: Treatment Of Effort Vein Thrombosismentioning

confidence: 99%

“…Other predisposing factors for UEDVT include indwelling hardware such as catheters or pacemaker wires, malignancy, and other hypercoagulable states. 2 Anatomic abnormalities involving the thoracic outlet are often implicated in SCV effort thrombosis. These abnormalities include congenital bands, hypertrophic scalenus anterior or subclavius muscle or tendon, abnormal clavicular or first rib anatomy or hypertrophy, and abnormal insertions of the costoclavicular ligament.…”

Section: Pathophysiologymentioning

confidence: 99%

Subclavian Effort Thrombosis: Pathophysiology, Diagnosis, and Management

King

Goldman

Schwenke

et al. 2022

Semin intervent Radiol

View full text Add to dashboard Cite

Subclavian vein (SCV) effort thrombosis, also known as Paget-Schroetter syndrome or venous thoracic outlet syndrome, is an uncommon condition that affects individuals with an irregularly narrow thoracic outlet who engage in repetitive overhead motions of the affected arm. Venous injury arises from microtraumas that occur from the repetitive compression of the SCV between the first rib and the overlying clavicle. Additional sources of extrinsic compression can be due to the anterior scalene muscle, subclavius muscle, and costoclavicular ligament. SCV effort thrombosis is a distinct entity from other forms of deep venous thrombosis and requires unique diagnostic and treatment considerations. Early catheter-directed therapy in the form of pharmacomechanical or catheter-directed thrombolysis combined with prompt surgical thoracic outlet decompression offers patients the best chances for early and durable symptom relief.

show abstract

“…In the setting of Paget-Schroetter in adults, there is significant evidence showing the success of thrombolytic therapy and CDT has become the primary method for establishing primary reperfusion ( 43 ). The data is much more limited in pediatrics as there is a case series that suggests CDT followed by rib enumeration and anticoagulation is safe and efficacious, but there was no a significant difference in the reported PTS or health related quality-of-life scores between the group that did get thrombolysis and the one that did not ( 22 ).…”

Section: Thrombolysis In Childrenmentioning

confidence: 99%

Thrombolysis in Children: A Case Report and Review of the Literature

et al. 2022

View full text Add to dashboard Cite

Thromboembolism (TE), including venous thromboembolism (VTE), arterial TE, arterial ischemic stroke (AIS), and myocardial infarction (MI), is considered a relatively rare complication in the pediatric population. Yet, the incidence is rising, especially in hospitalized children. The vast majority of pediatric TE occurs in the setting of at least one identifiable risk factor. Most recently, acute COVID-19 and multisystem inflammatory syndrome in children (MIS-C) have demonstrated an increased risk for TE development. The mainstay for the management pediatric TE has been anticoagulation. Thrombolytic therapy is employed more frequently in adult patients with ample data supporting its use. The data for thrombolysis in pediatric patients is more limited, but the utilization of this therapy is becoming more commonplace in tertiary care pediatric hospitals. Understanding the data on thrombolysis use in pediatric TE and the involved risks is critical before initiating one of these therapies. In this paper, we present the case of an adolescent male with acute fulminant myocarditis and cardiogenic shock likely secondary to MIS-C requiring extracorporeal life support (ECLS) who developed an extensive thrombus burden that was successfully resolved utilizing four simultaneous catheter-directed thrombolysis (CDT) infusions in addition to a review of the literature on the use of thrombolytic therapy in children.

show abstract

A systematic review and meta-analysis for the management of Paget-Schroetter syndrome

Cited by 25 publications

References 43 publications

Thoracic Outlet Syndrome: Single Center Experience on Robotic Assisted First Rib Resection and Literature Review

Thoracic Outlet Syndrome: Single Center Experience on Robotic Assisted First Rib Resection and Literature Review

Subclavian Effort Thrombosis: Pathophysiology, Diagnosis, and Management

Thrombolysis in Children: A Case Report and Review of the Literature

Contact Info

Product

Resources

About